Privacy search helps match subjects and trials

Pfizer is working with Private Access, a privacy-enhanced search technology company, to recruit clinical trial subjects. The collaborators are creating an online community that targets the No. 1 reason for patient unwillingness to participate in trials: fear that their health information will not remain confidential. The system will give patients control of personal health information by allowing them to define who gets access to the records and for what purposes. The restrictions provide a benefit to researchers, who will be able to see the records of only those patients whose conditions match their study focus. Pfizer release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.